Project aims to provide a catheter to deliver direct 3D, intraprocedural analysis of the success of cardiac ablation, in the treatment of atrial fibrillation.
As regulated companies, medical device firms must stay abreast of the latest developments to ensure they adopt new protocols to maintain quality assurance.
David Jensen, Staff Writer, MasterControl 04.09.21
U.K. bioelectronics company sets its sights on the U.S. market following a series of new investors, new product developments and a 156 percent sales surge.
Minimally invasive procedures are preferred over open surgeries due to less exposure to brain structures, rapid recovery time, and less tissue scarring.
With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors11.04.20